Tag: Low blood sugar

While semaglutide is designed to lower blood sugar in a glucose-dependent manner, a 2025 study flagged low blood sugar linked to GLP-1 weight-loss drugs. This highlights the importance of understanding if and when can semaglutide cause hypoglycemia, and what factors increase that risk.

A randomized controlled trial published in the *New England Journal of Medicine* found that oral propranolol was effective in treating infantile hemangioma, with 60% of infants receiving the optimal regimen showing complete or near-complete resolution. Understanding what does propranolol do to babies is crucial for parents and caregivers to ensure safe and effective treatment.

While Rybelsus (semaglutide) has a low intrinsic risk of causing hypoglycemia when used alone, the risk increases significantly when it is combined with other blood-sugar-lowering medications, such as insulin or sulfonylureas. Understanding this distinction is crucial for safe and effective diabetes management.

While Adderall is not specifically identified in diabetes guidelines as a primary cause of hypoglycemia, its stimulant properties can indirectly affect blood glucose regulation in a complex and sometimes unpredictable manner. As a result, it is important to understand the metabolic side effects and risks associated with Adderall, especially for people with diabetes.

Global research shows that 4 in 5 people with type 1 diabetes and nearly half with type 2 diabetes on insulin report a low blood sugar event over a four-week period [1.10.2]. Knowing when to use a glucagon emergency kit is critical for managing severe episodes.

According to clinical trial data, Zegalogue (dasiglucagon) demonstrated a median time to blood sugar recovery of just 10 minutes in adults with severe hypoglycemia. So, what is zegalogue for? It is a glucagon analog injection used as a rapid, life-saving rescue treatment for dangerously low blood sugar levels in individuals with diabetes.